Bristol-Myers Squibb Company
Utility Patents
Last updated:
List of all Bristol-Myers Squibb Company patents 334 in total
| Status | Patent |
|---|---|
Grant | Utility: Tricyclic sulfones as ROR.sub..gamma. modulators Filling date: 6 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: TL1A antibodies and uses thereof Filling date: 6 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Filling date: 6 Sep 2025 Issue date: 30 Mar 2021 |
Grant | Utility: Selective NR2B antagonists Filling date: 6 Sep 2025 Issue date: 30 Mar 2021 |
Grant | Utility: TGF beta receptor antagonists Filling date: 6 Sep 2025 Issue date: 30 Mar 2021 |
Grant | Utility: Substituted naphthyridinone compounds useful as T cell activators Filling date: 6 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Selective NR2B antagonists Filling date: 6 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Bispecific EGFR/IGFIR binding molecules Filling date: 6 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Cyclic dinucleotides as anticancer agents Filling date: 6 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Cyclic dinucleotides as anticancer agents Filling date: 6 Sep 2025 Issue date: 16 Mar 2021 |
Grant | Utility: Fibronectin based scaffold domain proteins that bind PCSK9 Filling date: 6 Sep 2025 Issue date: 16 Mar 2021 |
Grant | Utility: Methods of purifying proteins Filling date: 6 Sep 2025 Issue date: 16 Mar 2021 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Carbohydrate content of CTLA4 molecules Filling date: 6 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Serum albumin binding molecules Filling date: 6 Sep 2025 Issue date: 2 Mar 2021 |
Grant | Utility: Heterocyclic sulfones as ROR gamma modulators Filling date: 6 Sep 2025 Issue date: 2 Mar 2021 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 23 Feb 2021 |
Grant | Utility: Immunotherapeutic dosing regimens comprising pomalidomide and an anti-CS1 antibody for treating cancer Filling date: 6 Sep 2025 Issue date: 23 Feb 2021 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 16 Feb 2021 |
Grant | Utility: Compositions monovalent for CD28 binding and methods of use Filling date: 6 Sep 2025 Issue date: 16 Feb 2021 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 9 Feb 2021 |
Grant | Utility: [1,2,4]triazolo[1,5-A]pyridinyl substituted indole compounds Filling date: 6 Sep 2025 Issue date: 9 Feb 2021 |
Grant | Utility: Aminotriazolopyridines as kinase inhibitors Filling date: 6 Sep 2025 Issue date: 9 Feb 2021 |
Grant | Utility: Substituted 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazines as factor xia inhibitors Filling date: 6 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Substituted glycine derived FXIA inhibitors Filling date: 6 Sep 2025 Issue date: 26 Jan 2021 |
Grant | Utility: Modified self-immolating moieties for use in prodrugs and conjugates and methods of using and making Filling date: 6 Sep 2025 Issue date: 26 Jan 2021 |
Grant | Utility: Anti-ICOS agonist antibodies and uses thereof Filling date: 6 Sep 2025 Issue date: 26 Jan 2021 |
Grant | Utility: Process for the preparation of 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phe- nyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide Filling date: 6 Sep 2025 Issue date: 26 Jan 2021 |
Grant | Utility: Methods for maintaining pegylation of polypeptides Filling date: 6 Sep 2025 Issue date: 26 Jan 2021 |
Grant | Utility: Derivatives of uncialamycin, methods of synthesis and their use as antitumor agents Filling date: 6 Sep 2025 Issue date: 12 Jan 2021 |
Grant | Utility: 4-hydroxy-3-sulfonylpyridin-2(1H)-ones as APJ receptor agonists Filling date: 6 Sep 2025 Issue date: 12 Jan 2021 |
Grant | Utility: Compounds useful as immunomodulators Filling date: 6 Sep 2025 Issue date: 5 Jan 2021 |
Grant | Utility: Process for preparing tetrahydrocarbazole carboxamide compound Filling date: 6 Sep 2025 Issue date: 29 Dec 2020 |
Grant | Utility: Antiproliferative compounds and conjugates made therefrom Filling date: 6 Sep 2025 Issue date: 22 Dec 2020 |
Grant | Utility: Heterocyclic compounds useful as modulators of TNF alpha Filling date: 6 Sep 2025 Issue date: 15 Dec 2020 |
Grant | Utility: Carbohydrate content of CTLA4 molecules Filling date: 6 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Azole amides and amines as alpha v integrin inhibitors Filling date: 6 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Substituted bicyclic heterocyclic compounds Filling date: 6 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Nucleic acids encoding an anti-CD40 antibody Filling date: 6 Sep 2025 Issue date: 24 Nov 2020 |
Grant | Utility: Acyl sulfonamide NaV1.7 inhibitors Filling date: 6 Sep 2025 Issue date: 17 Nov 2020 |
Grant | Utility: Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or INF alpha responses Filling date: 6 Sep 2025 Issue date: 17 Nov 2020 |
Grant | Utility: Spiroheptane salicylamides and related compounds as inhibitors of ROCK Filling date: 6 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: Thienopyridines and benzothiophenes useful as IRAK4 inhibitors Filling date: 6 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation Filling date: 6 Sep 2025 Issue date: 3 Nov 2020 |
Grant | Utility: Monocyclic heteroaryl substituted compounds Filling date: 6 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Compositions and methods for producing a composition Filling date: 6 Sep 2025 Issue date: 20 Oct 2020 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use Filling date: 6 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Spiro-fused cyclic ureas as inhibitors of rock Filling date: 6 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Fibronectin type III domain proteins with enhanced solubility Filling date: 6 Sep 2025 Issue date: 29 Sep 2020 |
Showing 150 to 200 of 334 patents.